← Back to Search

Behavioral Intervention

Telerehabilitation for Low Vision (BeST-AID Trial)

N/A
Recruiting
Led By Ava K Bittner, OD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults with any level of vision loss due to any ocular disease who are age 18 and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 4 months, 8 months, 12 months, 13 months
Awards & highlights

BeST-AID Trial Summary

This trial aims to use telerehabilitation to improve quality of life for people with low vision and to monitor when they stop using their devices.

Who is the study for?
This trial is for adults over 18 with any level of vision loss from ocular disease, who've just received new magnification devices or visual assistive apps. It's not for those with conflicting schedules, substance abuse issues, severe hearing loss, major health conditions limiting participation or lifespan, communication difficulties regarding visual stimuli, need other low vision training, or have incompatible device features.Check my eligibility
What is being tested?
The study compares telerehabilitation to in-office care for follow-up training on using magnification devices and mobile apps to improve daily life activities. It also tests if beacon sensors can detect when patients stop using their low vision aids to prompt timely rehabilitation services.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like rehabilitation and sensor monitoring rather than drugs or invasive procedures, traditional side effects are not a concern. However, participants may experience frustration or fatigue during adaptation to the new technologies.

BeST-AID Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with vision loss from an eye condition.

BeST-AID Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 4 months, 8 months, 12 months, 13 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 4 months, 8 months, 12 months, 13 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Activity Inventory
Secondary outcome measures
Adherence to hand-held optical magnifier use (frequency and duration)
Informant surveys by close acquaintances of participants
International Reading Speed Text (IReST)
+4 more

BeST-AID Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telerehabilitation with low vision providerExperimental Treatment1 Intervention
Low Vision Rehabilitation for use of magnification or visual assistive devices using videoconferencing for remotely delivered follow-up care
Group II: Usual Care In-OfficeActive Control1 Intervention
Low Vision Rehabilitation in-office for use of magnification or visual assistive devices
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Vision Rehabilitation
2021
N/A
~150

Find a Location

Who is running the clinical trial?

University of NebraskaOTHER
539 Previous Clinical Trials
1,144,384 Total Patients Enrolled
Southern California College of Optometry at Marshall B. Ketchum UniversityOTHER
21 Previous Clinical Trials
1,016 Total Patients Enrolled
University of California, Los AngelesLead Sponsor
1,532 Previous Clinical Trials
10,264,918 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the accepted participant capacity for this experiment?

"This clinical trial requires 350 suitable candidates. Those looking to take part in this experiment can do so at the Chan Family Optometry clinic located in Grass Valley, Massachusetts or UCLA Stein Eye Institute located in Los Angeles, Michigan."

Answered by AI

How many healthcare facilities are presently conducting this experiment?

"This clinical trial is taking place at 10 different sites, including Grass Valley, Los Angeles and San Francisco. To minimize the burden of travel, it is recommended to select a site that is closest to you if you decide to participate."

Answered by AI

Are there still opportunities to join this medical experiment?

"As of October 24th 2023, this clinical trial is actively seeking applicants. The research was first made available to the public on 10/1/2023."

Answered by AI

Who else is applying?

What site did they apply to?
Southern Califonia College of Optometry
UCLA Stein Eye Institute
New England College of Optometry
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Most responsive sites:
  1. UCLA Stein Eye Institute: < 48 hours
Typically responds via
Phone Call
Average response time
  • < 2 Days
~233 spots leftby Jun 2028